Mercer Rachel M, Psallidas Ioannis, Rahman Najib M
a University of Oxford Respiratory Trials Unit , Churchill Hospital , Oxford , UK.
b Oxford Centre for Respiratory Medicine , Oxford University Hospitals NHS Trust , Oxford , UK.
Expert Rev Respir Med. 2017 Apr;11(4):323-331. doi: 10.1080/17476348.2017.1300531. Epub 2017 Mar 6.
Pleural disease encompasses a large range of conditions, is a common presentation to the acute medical take and often requires comprehensive investigation and treatment. Ultrasound is well recognised as a useful investigative tool in pleural disease especially in the field of pleural effusion, pleural thickening and interventional procedures. Thoracic ultrasound (TUS) has gained widespread use by physicians as evidence has shown a reduced rate of complications when performing pleural procedures with ultrasound guidance. Areas covered: This article will review studies assessing the role of TUS in the management of pleural disease and examine ongoing research into how TUS could advance our knowledge and understanding over the next decade. Expert commentary: Physician lead thoracic ultrasound has become commonplace over the last decade, and now represents a minimum standard of safety in conducting the majority of 'bedside' pleural procedures. The current evidence points to important diagnostic and procedural roles of the use of bedside thoracic ultrasound. In the future, research developments are likely to lead to the use of thoracic ultrasound in prognostication, targeted treatment and understanding pathogenesis in pleural disease.
胸膜疾病涵盖多种病症，是急性内科诊治中常见的情况，通常需要全面的检查和治疗。超声作为胸膜疾病尤其是胸腔积液、胸膜增厚及介入操作领域中一种有用的检查工具，已得到广泛认可。胸部超声（TUS）已被医生广泛应用，因为有证据表明在超声引导下进行胸膜操作时并发症发生率降低。涵盖领域：本文将回顾评估TUS在胸膜疾病管理中作用的研究，并探讨正在进行的关于TUS在未来十年如何增进我们的知识和理解的研究。专家评论：在过去十年中，医生主导的胸部超声已变得很普遍，现在它代表了进行大多数“床边”胸膜操作的最低安全标准。目前的证据表明床边胸部超声在诊断和操作方面具有重要作用。未来，研究进展可能会导致胸部超声在胸膜疾病的预后评估、靶向治疗和发病机制理解方面的应用。
